Fig 8 - حسب Farshid Maleki (20521649)

الموضوعات:

Schematic presentation of mechanism of anti-cancer activity of ATO and GCB combination in breast cancer cells. حسب Farshid Maleki (20521649)

الموضوعات:

XRD pattern for the prepared titanium oxide nanofibers. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Fig 4 - حسب Farshid Maleki (20521649)

الموضوعات:

Plasticity limit (%) of pristine and modified Egyptian kaolin. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Thermal gravimetric analyses and the first derivative for the obtained data for the PVA; (A and B) and TiO₂; (C and D) compared with the pristine kaolin. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Chemical composition (%) of the Egyptian clay [9]. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Compression strength of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Two magnifications SEM; (A and B) and TEM (C and D) images for the produced TiO₂ nanofibers. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Fig 9 - حسب Farshid Maleki (20521649)

الموضوعات:

Apparent density of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Water absorption of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Trypan blue dye exclusion assay for cell viability evaluation (% of control). حسب Farshid Maleki (20521649)

الموضوعات:

Percentage change in the apparent density of pristine and modified Egyptian kaolin sintered at 1050 °C for 4 successive cycles. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Fig 7 - حسب Farshid Maleki (20521649)

الموضوعات:

Porosity of pristine and modified Egyptian kaolin sintered at two temperatures: 900 and 1050 °C. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Rate of apoptosis in MDA-MB-231 cells (ATO: 2.5 μM and GCB: 22.5 μM, 48 h, at 37°C). حسب Farshid Maleki (20521649)

الموضوعات:

Fig 10 - حسب Farshid Maleki (20521649)

الموضوعات:

XRD pattern for the prepared silicon oxide nanoparticles. حسب Nasser A. M. Barakat (11705885)

الموضوعات:

Fig 5 - حسب Farshid Maleki (20521649)

الموضوعات: